MX2009002653A - Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular". - Google Patents

Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular".

Info

Publication number
MX2009002653A
MX2009002653A MX2009002653A MX2009002653A MX2009002653A MX 2009002653 A MX2009002653 A MX 2009002653A MX 2009002653 A MX2009002653 A MX 2009002653A MX 2009002653 A MX2009002653 A MX 2009002653A MX 2009002653 A MX2009002653 A MX 2009002653A
Authority
MX
Mexico
Prior art keywords
hyaluronic acid
click chemistry
crosslinking
acid derivatives
obtained via
Prior art date
Application number
MX2009002653A
Other languages
English (en)
Inventor
Vittorio Crescenzi
Chiara Dimeo
Devis Galesso
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Publication of MX2009002653A publication Critical patent/MX2009002653A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a derivados reticulados de polisacáridos policarboxilados, en donde al menos una de las cadenas de polisacárido consiste de ácido hialurónico o un derivado del mismo, reticuladas por medio de reacciones del tipo de "química modular" y su uso en el campo de viscosuplementación, cirugía plástica, oncología y cirugía reconstructiva y también como matrices para sistemas de liberación controlada de moléculas y/o macromoléculas biológicamente y/o farmacológicamente activas.
MX2009002653A 2006-09-11 2007-09-05 Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular". MX2009002653A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001726A ITMI20061726A1 (it) 2006-09-11 2006-09-11 Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
PCT/EP2007/007758 WO2008031525A1 (en) 2006-09-11 2007-09-05 Hyaluronic acid derivatives obtained via 'click chemistry' crosslinking

Publications (1)

Publication Number Publication Date
MX2009002653A true MX2009002653A (es) 2009-05-15

Family

ID=38728969

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002653A MX2009002653A (es) 2006-09-11 2007-09-05 Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular".

Country Status (13)

Country Link
US (1) US8512752B2 (es)
EP (1) EP2061816B1 (es)
JP (1) JP5397770B2 (es)
KR (1) KR20090063235A (es)
CN (1) CN101528780B (es)
AU (1) AU2007296939B9 (es)
CA (1) CA2662924C (es)
ES (1) ES2620400T3 (es)
IL (1) IL197498A (es)
IT (1) ITMI20061726A1 (es)
MX (1) MX2009002653A (es)
PL (1) PL2061816T3 (es)
WO (1) WO2008031525A1 (es)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2347775T (pt) 2005-12-13 2020-07-14 The President And Fellows Of Harvard College Estruturas em andaime para transplante celular
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
AU2013203710B2 (en) * 2007-11-30 2016-09-29 Allergan Industrie, Sas Polysaccharide gel formulation
JP5690143B2 (ja) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 持続的細胞プログラミング装置
EP2254944B1 (en) * 2008-02-29 2018-12-19 PVAC Medical Technologies Ltd. Composition for the formation of gels
US8034396B2 (en) * 2008-04-01 2011-10-11 Tyco Healthcare Group Lp Bioadhesive composition formed using click chemistry
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
GB0816783D0 (en) 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
WO2010096654A1 (en) 2009-02-21 2010-08-26 Tyco Healthcare Group Lp Medical devices having activated surfaces
WO2010095056A2 (en) 2009-02-21 2010-08-26 Sofradim Production Medical devices with an activated coating
CA2753217A1 (en) * 2009-02-21 2010-08-26 Sofradim Production Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
US8968733B2 (en) 2009-02-21 2015-03-03 Sofradim Production Functionalized surgical adhesives
ES2415161T3 (es) * 2009-02-21 2013-07-24 Sofradim Production Dispositivo médico y procedimiento de fabricación del mismo
AU2010215192B2 (en) 2009-02-21 2015-04-30 Sofradim Production Amphiphilic compounds and self-assembling compositions made therefrom
AU2010215199B2 (en) 2009-02-21 2015-01-15 Sofradim Production Compounds and medical devices activated with solvophobic linkers
AU2010215202A1 (en) 2009-02-21 2011-10-13 Covidien Lp Crosslinked fibers and method of making same using UV radiation
US8512728B2 (en) 2009-02-21 2013-08-20 Sofradim Production Method of forming a medical device on biological tissue
US8535477B2 (en) 2009-02-21 2013-09-17 Sofradim Production Medical devices incorporating functional adhesives
EP2398523B1 (en) 2009-02-21 2018-04-04 Covidien LP Medical devices having activated surfaces
US8663689B2 (en) 2009-02-21 2014-03-04 Sofradim Production Functionalized adhesive medical gel
US9375699B2 (en) 2009-02-21 2016-06-28 Sofradim Production Apparatus and method of reacting polymers by exposure to UV radiation to produce injectable medical devices
US8648144B2 (en) 2009-02-21 2014-02-11 Sofradim Production Crosslinked fibers and method of making same by extrusion
US8877170B2 (en) 2009-02-21 2014-11-04 Sofradim Production Medical device with inflammatory response-reducing coating
FR2951449B1 (fr) * 2009-10-15 2011-11-25 Commissariat Energie Atomique Procede de fonctionnalisation de molecules biologiques
CZ2009835A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
EP2361640A1 (en) * 2010-02-25 2011-08-31 Université de Liège Cell cultivation in chitosan alginate hydrogel beads
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
HUE043344T2 (hu) 2010-03-22 2019-08-28 Allergan Inc Térhálósított hidrogélek lágy szövet növelésére
CA2794335A1 (en) 2010-03-25 2011-09-29 Sofradim Production Medical devices incorporating functional adhesives
CA2794336A1 (en) 2010-03-25 2011-09-29 Sofradim Production Surgical fasteners and methods for sealing wounds
US9247931B2 (en) 2010-06-29 2016-02-02 Covidien Lp Microwave-powered reactor and method for in situ forming implants
AU2011273102A1 (en) 2010-07-01 2013-01-31 Sofradim Production Medical device with predefined activated cellular integration
CA2805987C (en) 2010-07-27 2019-04-09 Sofradim Production Polymeric fibers having tissue reactive members
CZ305040B6 (cs) 2010-09-14 2015-04-08 Contipro Biotech S.R.O. Způsob přípravy vysoce substituovaných amidů kyseliny hyaluronové
WO2012044753A2 (en) 2010-10-01 2012-04-05 Applied Medical Resources Corporation Portable laparoscopic trainer
WO2012048165A2 (en) 2010-10-06 2012-04-12 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
KR101003687B1 (ko) * 2010-10-19 2010-12-23 (주)소우영 히알루론산계 화합물, 그 제조방법 및 용도
FR2967677B1 (fr) 2010-11-18 2014-05-16 Centre Nat Rech Scient Derives de polysaccharides comprenant un motif alcene et reaction de couplage par chimie thio-clic
TR201903325T4 (tr) * 2010-11-23 2019-04-22 Allergan Pharmaceuticals Int Ltd Polisakkaritlerle çapraz bağlanan proteinlerin hazırlanması ve/veya formülü.
FI125829B (fi) 2011-03-07 2016-02-29 Aalto Korkeakoulusã Ã Tiã Double click-teknologia
CZ304072B6 (cs) * 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
EP2701745B1 (en) * 2011-04-28 2018-07-11 President and Fellows of Harvard College Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
JPWO2012165462A1 (ja) * 2011-05-31 2015-02-23 国立大学法人 東京大学 ハイドロゲル及びその製造方法
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
RU2624239C2 (ru) 2011-06-03 2017-07-03 Аллерган, Инк. Составы кожного наполнителя, включая антиоксиданты
EP2714073B1 (en) 2011-06-03 2021-03-10 President and Fellows of Harvard College In situ antigen-generating cancer vaccine
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
KR101963610B1 (ko) 2011-10-21 2019-03-29 어플라이드 메디컬 리소시스 코포레이션 수술 트레이닝용 모의 조직 구조
CN102532502B (zh) * 2011-12-13 2013-09-04 暨南大学 生物功能化可降解聚酯及其制备方法
US8961190B2 (en) 2011-12-20 2015-02-24 Applied Medical Resources Corporation Advanced surgical simulation
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CA2870309C (en) 2012-04-16 2024-02-20 President And Fellows Of Harvard College Mesoporous silica compositions for modulating immune responses
CN102772823A (zh) * 2012-07-25 2012-11-14 华南理工大学 透明质酸/明胶/硫酸软骨素骨修复仿生支架的制备方法
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
KR102105979B1 (ko) 2012-09-26 2020-05-04 어플라이드 메디컬 리소시스 코포레이션 복강경 절차들을 위한 수술 훈련 모델
US10679520B2 (en) 2012-09-27 2020-06-09 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
US9750827B2 (en) 2013-02-22 2017-09-05 Canon Kabushiki Kaisha Near-infrared dye-conjugated hyaluronic acid derivative and contrast agent for optical imaging including them
JP6482478B2 (ja) 2013-03-01 2019-03-13 アプライド メディカル リソーシーズ コーポレイション 手術シミュレーションシステム及び方法
CN104056298B (zh) * 2013-03-18 2017-04-26 李锋 无规共聚物的伤口应用
US9775928B2 (en) 2013-06-18 2017-10-03 Covidien Lp Adhesive barbed filament
EP3301662B1 (en) 2013-06-18 2023-06-07 Applied Medical Resources Corporation Gallbladder model
KR102239454B1 (ko) 2013-07-24 2021-04-13 어플라이드 메디컬 리소시스 코포레이션 제 1 진입 모델
US10198966B2 (en) 2013-07-24 2019-02-05 Applied Medical Resources Corporation Advanced first entry model for surgical simulation
JP2016172783A (ja) * 2013-08-08 2016-09-29 生化学工業株式会社 組織膨隆材
US10047172B2 (en) 2013-09-30 2018-08-14 Galderma S.A. Single step functionalization and cross-linking of hyaluronic acid
EP3103807B1 (en) * 2014-02-06 2021-08-25 Japan Science And Technology Agency Peptide/ beta-1,3-glucan complex and production method therefor, and pharmaceutical composition containing peptide/ beta-1,3-glucan complex
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
AU2015235994B2 (en) 2014-03-26 2019-11-21 Applied Medical Resources Corporation Simulated dissectible tissue
ES2811301T3 (es) * 2014-04-04 2021-03-11 Harvard College Hidrogeles reticulados por química clic y métodos de uso
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
EP3218892B1 (en) 2014-11-13 2019-10-23 Applied Medical Resources Corporation Simulated tissue models and methods
WO2016123573A1 (en) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
KR20230143198A (ko) 2015-02-19 2023-10-11 어플라이드 메디컬 리소시스 코포레이션 시뮬레이션된 조직 구조체들 및 방법들
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
US11150242B2 (en) 2015-04-10 2021-10-19 President And Fellows Of Harvard College Immune cell trapping devices and methods for making and using the same
EP3286247A4 (en) 2015-04-24 2018-12-26 The Penn State Research Foundation Clickable waterborne polymers and click-crosslinked waterborne polymers
KR20180008417A (ko) 2015-05-14 2018-01-24 어플라이드 메디컬 리소시스 코포레이션 전기수술 트레이닝 및 시뮬레이션을 위한 합성 조직 구조체
WO2016201085A1 (en) 2015-06-09 2016-12-15 Applied Medical Resources Corporation Hysterectomy model
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
AU2016291726B2 (en) 2015-07-16 2022-02-03 Applied Medical Resources Corporation Simulated dissectable tissue
US10490105B2 (en) 2015-07-22 2019-11-26 Applied Medical Resources Corporation Appendectomy model
EP4300467A3 (en) 2015-10-02 2024-04-03 Applied Medical Resources Corporation Hysterectomy model
US10706743B2 (en) 2015-11-20 2020-07-07 Applied Medical Resources Corporation Simulated dissectible tissue
CN105504316B (zh) * 2016-01-29 2017-12-29 清华大学 一种透明质酸‑甲基纤维素复合凝胶的活性酯交联方法
CN115531609A (zh) 2016-02-06 2022-12-30 哈佛学院校长同事会 重塑造血巢以重建免疫
CN107400247B (zh) * 2016-05-19 2020-04-28 北京化工大学 一种原位交联水凝胶
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
WO2018005301A1 (en) 2016-06-27 2018-01-04 Applied Medical Resources Corporation Simulated abdominal wall
CN115305229A (zh) 2016-07-13 2022-11-08 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
EP3583589A1 (en) 2017-02-14 2019-12-25 Applied Medical Resources Corporation Laparoscopic training system
US10847057B2 (en) 2017-02-23 2020-11-24 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
JP7216006B2 (ja) 2017-03-22 2023-01-31 ジェネンテック， インコーポレイテッド ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
CN110476266A (zh) * 2017-03-29 2019-11-19 日立化成株式会社 电荷输送性材料及其用途
JOP20190245A1 (ar) 2017-04-20 2019-10-15 Novartis Ag أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
US20220088274A1 (en) * 2017-05-18 2022-03-24 The Board Of Trustees Of The Leland Stanford Junior University Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue
KR102071111B1 (ko) * 2017-10-11 2020-01-29 아주대학교산학협력단 성장인자 모사 펩타이드가 도입된 생체물질, 이의 제조방법 및 이의 응용
KR102103180B1 (ko) * 2017-12-22 2020-04-22 케이비바이오메드 주식회사 히알루론산유도체, 플루란 및 카르복시메틸 셀룰로오스를 포함하는 유착방지용 조성물 및 이의 제조방법
FI129257B (en) * 2017-12-29 2021-10-15 Fortum Oyj Method for derivatizing cellulose
KR102213196B1 (ko) * 2018-05-08 2021-02-05 주식회사 메디폴리머 클릭화학 반응을 통해 필러 또는 약물전달체로 사용하기 위한 주사제형 조성물
CN108721695A (zh) * 2018-05-29 2018-11-02 金陵科技学院 一种可注射性复合水凝胶细胞载体支架的制备方法
US20210198433A1 (en) * 2018-05-31 2021-07-01 Universiteit Gent Bifunctional modified biopolymer based polymers and hydrogels obtainable from such bifunctional modified biopolymer based polymers
CA3103227A1 (en) 2018-06-14 2019-12-19 Mochida Pharmaceutical Co., Ltd. Novel crosslinked alginic acid
CN116891541A (zh) * 2018-06-28 2023-10-17 哈鲁拉公司 交联的多羧酸化多糖及其使用方法
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
CN109735819B (zh) * 2019-03-14 2020-01-31 西南交通大学 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法
US20220213233A1 (en) * 2019-04-19 2022-07-07 Jointherapeutics S.R.L. Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
KR102152939B1 (ko) * 2019-04-30 2020-09-07 한국화학연구원 공유결합성 트리아졸로 연결된 가시광선 흡수 광촉매, 이의 제조방법 및 이를 이용한 아자이드-알카인 고리화 첨가반응으로 트리아졸 유도체를 제조하는 방법
WO2021060336A1 (ja) * 2019-09-25 2021-04-01 持田製薬株式会社 新規な架橋アルギン酸構造体
KR102365327B1 (ko) * 2019-10-04 2022-02-18 부경대학교 산학협력단 근적외선을 이용한 외부자극 감응형 하이드로겔 담체, 이의 제조방법 및 이를 이용한 약물 전달 시스템
CN114929754A (zh) 2019-12-18 2022-08-19 持田制药株式会社 新型交联海藻酸
CA3188951A1 (en) * 2020-08-14 2022-02-17 The University Of Tokyo Polysaccharide derivative, polysaccharide derivative-drug conjugate, and method for producing same
CN113214504A (zh) * 2021-04-20 2021-08-06 河南工业大学 一种基于天然高分子的半互穿网络抑菌凝胶的制备方法
CN113667141B (zh) * 2021-07-09 2023-10-03 深圳华源再生医学有限公司 抗蛋白粘附的海藻酸盐水凝胶及其制备方法和应用
CN115068671B (zh) * 2022-06-20 2023-07-28 常州华联医疗器械集团股份有限公司 一种海藻酸钠水凝胶敷料的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US6673905B2 (en) * 2000-08-09 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Conjugation of biomolecules using Diels-Alder cycloaddition
IT1317358B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
JP4172176B2 (ja) * 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
AU2003240482B2 (en) * 2002-05-30 2009-03-12 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
US20050032081A1 (en) * 2002-12-13 2005-02-10 Jingyue Ju Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
WO2007003054A1 (en) * 2005-07-06 2007-01-11 Shoichet Molly S Method of biomolecule immobilization on polymers using click-type chemistry
WO2007035296A2 (en) 2005-09-15 2007-03-29 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
WO2007132005A2 (fr) * 2006-05-15 2007-11-22 Rhodia Operations Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications

Also Published As

Publication number Publication date
KR20090063235A (ko) 2009-06-17
CA2662924A1 (en) 2008-03-20
EP2061816A1 (en) 2009-05-27
JP2010502824A (ja) 2010-01-28
CN101528780A (zh) 2009-09-09
IL197498A0 (en) 2009-12-24
CN101528780B (zh) 2013-05-15
JP5397770B2 (ja) 2014-01-22
US8512752B2 (en) 2013-08-20
EP2061816B1 (en) 2017-02-22
US20100291171A1 (en) 2010-11-18
IL197498A (en) 2014-02-27
CA2662924C (en) 2014-11-04
AU2007296939B9 (en) 2012-07-19
AU2007296939B2 (en) 2012-07-05
PL2061816T3 (pl) 2017-08-31
AU2007296939A1 (en) 2008-03-20
ITMI20061726A1 (it) 2008-03-12
WO2008031525A1 (en) 2008-03-20
ES2620400T3 (es) 2017-06-28

Similar Documents

Publication Publication Date Title
MX2009002653A (es) Derivados de acido hialuronico obtenidos via reticulacion de "quimica modular".
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
JP2008508959A5 (es)
TW200704649A (en) Water-absorbing polymer structures based upon renewable raw materials and process for their production
BRPI0416590A (pt) excipientes em veìculos de distribuição de fármacos
UA117216C2 (uk) Пухлиноасоційований пептид та його застосування
AU2003901834A0 (en) Cross-linked polysaccharide compositions
GB0329825D0 (en) Biological products
MX339797B (es) Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
DE60017831D1 (de) Dermale zusammensetzungen
EA200971116A1 (ru) Способ желатинизации фиброина шелка с применением обработки ультразвуком
TW200716205A (en) Pharmaceutical compositions comprising imatinib and a release retardant
NZ705384A (en) Composition for treating hyperlipidemia comprising oxyntomodulin derivative
WO2010078036A3 (en) Biocompatible polysaccharide-based hydrogels
WO2009073508A3 (en) Polysaccharide gel compositions and methods for sustained delivery of drugs
WO2010017264A3 (en) Photo-crosslinked nucleic acid hydrogels
TW200617055A (en) Use of polymers for upconversion and devices for upconversion
WO2007006403A3 (en) Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process
WO2003084481A3 (en) Biological affinity based delivery systems
MXPA06002349A (es) Derivados de aminopropanol.
WO2007067828A3 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
DK1773399T3 (da) Hydrogeler af hyaluronsyre og alfa,beta-polyaspartylhydrazid og deres biomedicinske og farmaceutiske anvendelser
EP2019133A8 (en) MICROORGANISM CAPABLE OF PRODUCING gamma-L-PGA, METHOD FOR PRODUCTION OF gamma-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN
MX2010004523A (es) Dispersantes para sistemas de fraguado hidraulico.
EP1469886B8 (en) Lyophilized pharmaceutical composition of propofol

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration